Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 15Head & Neck 3Thoracic 2Tumor-Agnostic 1Other solid neoplasm 1Myeloid 1Gynecologic 1CNS 1Breast 1

Conditions

Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Histiocytosis 1Brain Neoplasms 1

Interventions

Carboplatin 202pembrolizumab 166Pemetrexed 140Cisplatin 124Paclitaxel 77durvalumab 74osimertinib 69Nivolumab 68Docetaxel 66Specimen Handling 64atezolizumab 57Magnetic Resonance Spectroscopy 53Etoposide 47Gemcitabine 46Radiotherapy 43Radiosurgery 40130-nm albumin-bound paclitaxel 34Drug Therapy 32Bevacizumab 29Ipilimumab 28Cetuximab 27cemiplimab 25Taxes 24tislelizumab 21Immunoglobulin G 21Platinum 20Biopsy 20amivantamab 19Radiation 19Disulfides 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Panitumumab × Thoracic × 90 days × Clear all
NCT07094204 2026-05-18

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
364 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡